Clinical Trial Update: Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of concomitant chemoradiotherapy with VIDL chemotherapy in extranodal NK/T-cell lymphoma, nasal type, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• VIDL chemotherapy

Snippet

Sponsor: Samsung Medical Center | Conditions: NK/T-cell Lymphoma of Nasal Cavity | Phase 2 | Status: COMPLETED | Results posted: 2019-02-07